BRANMOOR
THURSDAY · 14 MAY 2026

Furosemide

Injection

Current Active — Day 2228 FDA record updated

Moderate impact — Limited manufacturing base (2 known suppliers); substitute sourcing may be constrained.

FDA shortage record

Substance
Furosemide
Manufacturers / suppliers
  • Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
  • Avet Pharmaceuticals, Inc.
2 known suppliers in current FDA data
Dosage form
Injection
Presentation
Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-44)
Route(s)
INTRAVENOUS
Therapeutic category
Cardiovascular
Package NDC
23155-473-44
Initially posted
04/07/2020
Days on shortage list
2228
Current FDA status
Current
Shortage entries (current dataset)
2 records for Furosemide

Why this shortage matters

Cardiovascular drugs manage heart failure, arrhythmias, hypertension, and coronary artery disease. Shortages can disrupt stable long-term therapy or create gaps in acute care where dosing consistency is essential to preventing cardiac events.

FDA therapeutic class: Cardiovascular

Manufacturer contact

Per the FDA record, the manufacturer's contact for supply inquiries is 855-228-9470.

If you're affected by this shortage

  • Talk to your prescribing clinician or pharmacist about therapeutic alternatives. Do not switch medications on your own.
  • Ask your pharmacy to check supply across multiple wholesalers and other branches.
  • Check current pharmacy pricing and availability via GoodRx (affiliate link).
  • Report a continuing supply problem to FDA via the FDA Drug Shortages contact form.

Sources

Important

This page reproduces publicly available FDA shortage data for informational purposes only. It is not medical advice and does not establish a clinician-patient relationship. Shortage status changes frequently; verify directly with your pharmacist or the FDA Drug Shortages site before making any treatment decision.